Skip to main content
. 2010 Dec 21;9:318. doi: 10.1186/1476-4598-9-318

Figure 1.

Figure 1

FBI-1 was overexpressed in ovarian tumors and correlated with prognosis of patients. A, Representative images of FBI-1 immunoreactivity in different ovarian tumor subtypes and malignant ascites (20×) (bottom right; 200×). B, mRNA expression (upper left panel) and gene amplification status (upper right panel) of FBI-1 in clinical samples and the correlation of gene amplification patterns with mRNA expression (lower panel). C, High expression of FBI-1 was associated with poor overall and disease-free survival.